UNC5A and central nervous system cancer: In order to give a quantitative way for predicting the 1-, 3-, and 5-year OS rates in glioma patients, we also created a Norman chart incorporating UNC5A expression and clinicopathological characteristics, evaluating it by calibration plots, C-index, and ROC curves (Fig. 5C).